Authors: | Segal, N. H.; Reidy-Lagunes, D.; Capanu, M.; Kemeny, N.; Chung, K.; Kelsen, D.; Hollywood, E.; Goodman-Davis, N.; Saltz, L. B. |
Abstract Title: | Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study) |
Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
Journal Title: | Journal of Clinical Oncology |
Volume: | 27 |
Issue: | 15 Suppl. |
Meeting Dates: | 2009 May 29-Jun 2 |
Meeting Location: | Orlando, FL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2009-05-20 |
Start Page: | 189s |
Language: | English |
ACCESSION: | WOS:000276606601029 |
PROVIDER: | wos |
DOI: | 10.1200/jco.2009.27.15_suppl.4087 |
Notes: | Meeting Abstract: 4087 -- Source: Wos |